Immune reconstitution inflammatory syndrome in HIV-infected patients with and without prior tuberculosis

International Journal of STD and AIDS

Volumn 23, Issue 6, 2012, Pages 419-423

  Ramesh Kumar, S ^a   Gopalan, Narendran ^a   Patrawalla, Paru ^b   Menon, Pradeep ^a   Mayer, Kenneth ^c   Swaminathan, Soumya ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b BOSTON MEDICAL CENTER   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

Antiretroviral therapy; HIV; Immune reconstitution inflammatory syndrome; India; IRIS; Robertson score tuberculosis; TB

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EFAVIRENZ; ETHAMBUTOL; ISONIAZID; LAMIVUDINE; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; CYTOMEGALOVIRUS RETINITIS; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; LUNG TUBERCULOSIS; MALE; MONOTHERAPY; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INDIA; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS;

EID: 84864064768     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009439     Document Type: Article

References (17)

1. http://www.inshi.umn.edu/ (last checked 10 May 2009)
2. WHO. 2006 Revision Recommendation of ART for Adults and Adolescents. See http:// www.who.int/hiv/pub/guidelines/artadultguidelines.pdf (last checked 27 January 2009)
3. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-427
4. Shelburne SA, Visnegarwala F, Darcourt J, et al. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005;19:399-406
5. Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007;21:335-341
6. Zampoli M, Kilborn T, Eley B. Tuberculosis during early antiretroviral-induced immune reconstitution in HIV-infected children. Int J Tuberc Lung Dis 2007;11:417-423
7. Orlovic D, Smego RA Jr. Paradoxical tuberculous reactions in HIV-infected patients. Int J Tuberc Lung Dis 2001;5:370-375
8. Murdoch DM, Venter WD, Feldman C, Van Rie A, David M. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 2008;22:601-610
9. Kumarasamy N, Chaguturu S, Mayer KH, et al. Incidence of immune reconstitution syndrome in HIV/Tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr 2004;37:1574-1576
10. Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis 2006;42:1639-1646
11. NACO guidelines. See http:// www.nacoonline.org/NACO (last checked 11 September 2009)
12. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 3 November 2008. See http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (last checked 19 March 2009)
13. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006;57:167-170
14. Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006;20:F1-F7
15. Shankar EM, Vignesh R, Murugavel KG, et al. Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities. AIDS Res Ther 2007;4:29
16. Zhou J, Ditangco R, TREAT Asia HIV Observational Database. Predicting immune reconstitution syndrome. Clin Infect Dis 2007;44:147-148
17. Meintjes G, Lawn SD, Scano F, et al., International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008;8:516-523